Loading
Latest filing published 18 Nov 2025 for Bioxytran, INC, €12k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Anders Utter (board member) discloses dealings in Bioxytran, Inc to SEC (Form 4). The record holds 12 filings, for trades running from 2 April 2021 to 14 November 2025.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Most recently, on 18 November 2025, the filings show a share grant worth €12k in Bioxytran, Inc. Typically, a trade is published a median of 4 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations